Page 554 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 554

540     SECTION V  Drugs That Act in the Central Nervous System


                 TABLE 30–1  Pharmacokinetic profiles of selected antidepressants.

                                                                    Active Metabolite   Volume of
                  Class, Drug     Bioavailability (%)  Plasma t 1/2  (hours)  t 1/2  (hours)  Distribution (L/kg)  Protein Binding (%)
                  SSRIs                                                                                
                    Citalopram        80               33–38            ND              15                   80
                    Escitalopram      80               27–32            ND              12–15                80
                    Fluoxetine        70               48–72            180             12–97                95
                    Fluvoxamine       90               14–18            14–16           25                   80
                    Paroxetine        50               20–23            ND              28–31                94
                    Sertraline        45               22–27            62–104          20                   98
                  SNRIs                                                                                       
                    Duloxetine        50               12–15            ND              10–14                97
                    Milnacipran       85–90            6–8              ND              5–6                  13
                    Venlafaxine 1     45               8–11             9–13            4–10                 27
                  Tricyclics                                                                                  
                    Amitriptyline     45               31–46            20–92           5–10                 90
                    Clomipramine      50               19–37            54–77           7–20                 97
                    Imipramine        40               9–24             14–62           15–30                84
                  5-HT modulators                                                                             
                    Nefazodone        20               2–4              ND              0.5–1                99
                    Trazodone         95               3–6              ND              1–3                  96
                    Vortioxetine      75               66               ND              ND                   98
                  Tetracyclics and                                                                            
                  unicyclic
                    Amoxapine         ND               7–12             5–30            0.9–1.2              85
                    Bupropion         70               11–14            15–25           20–30                85
                    Maprotiline       70               43–45            ND              23–27                88
                    Mirtazapine       50               20–40            20–40           3–7                  85
                    Vilazodone        72               25               ND              ND                   ND
                  MAOIs                                                                                       
                    Phenelzine        ND               11               ND              ND                   ND
                    Selegiline        4                8–10             9–11            8–10                 99
                 1 Desvenlafaxine has similar properties but is less completely metabolized.
                 MAOIs, monoamine oxidase inhibitors; ND, no data found; SNRIs, serotonin-norepinephrine reuptake inhibitors; SSRIs, selective serotonin reuptake inhibitors.



                   Fluoxetine and paroxetine are potent inhibitors of the CYP2D6   most  antidepressants, desvenlafaxine  is conjugated and does not
                 isoenzyme, and this contributes to potential drug interactions (see   undergo extensive oxidative metabolism. At least 45% of desvenla-
                 Drug Interactions). In contrast, fluvoxamine is an inhibitor of   faxine is excreted unchanged in the urine compared with 4–8% of
                 CYP3A4, whereas citalopram, escitalopram, and sertraline have   venlafaxine.
                 more modest CYP interactions.                          Duloxetine is well absorbed and has a half-life of 12–15 hours
                                                                     but is dosed once daily. It is tightly bound to protein (97%)
                 B. Serotonin-Norepinephrine Reuptake Inhibitors     and undergoes extensive oxidative metabolism via CYP2D6 and
                 1.  Selective  serotonin-norepinephrine  reuptake   CYP1A2. Hepatic impairment significantly alters duloxetine levels
                 inhibitors—Venlafaxine is extensively metabolized in the liver via   unlike desvenlafaxine.
                 the CYP2D6 isoenzyme to  O-desmethylvenlafaxine (desvenlafax-  Both milnacipran and levomilnacipran are well absorbed after
                 ine). Both have similar half-lives of about 8–11 hours. Despite the   oral dosing. Both have shorter half-lives and lower protein binding
                 relatively short half-lives, both drugs are available in formulations   than venlafaxine (Table 30–1). Milnacipran and levomilnacipran
                 that allow once-daily dosing. Venlafaxine and desvenlafaxine have   are largely excreted unchanged in the urine. Levomilnacipran also
                 the lowest protein binding of all antidepressants (27–30%). Unlike   undergoes desethylation via 3A3/4.
   549   550   551   552   553   554   555   556   557   558   559